Related Experiment Video
Updated: Mar 13, 2026

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
Published on: January 15, 2018
Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.
Daniel Vocelle1, Olivia M Chesniak2, Amanda P Malefyt1
1Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI 48824-1226, USA.
Dextran-functionalized silica nanoparticles improve short interfering RNA (siRNA) delivery. This novel approach utilizes scavenger receptor-mediated endocytosis for enhanced cellular uptake, paving the way for more effective RNA interference therapeutics.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Effective delivery of short interfering RNA (siRNA) is crucial for RNA interference (RNAi) therapeutics.
- Intracellular trafficking of siRNA delivery vehicles presents a significant challenge in therapeutic development.
Purpose of the Study:
- To investigate the role of dextran functionalization in silica nanoparticle-mediated siRNA delivery.
- To elucidate the endocytosis pathway utilized by dextran-functionalized silica nanoparticles for siRNA delivery.
Main Methods:
- Utilized dextran-functionalized silica nanoparticles for siRNA delivery in cultured cells.
- Employed pharmacological inhibitors to dissect the endocytic pathways involved.
- Analyzed cellular uptake and intracellular trafficking mechanisms.
Main Results:
- Dextran functionalization significantly enhanced cellular uptake and intracellular delivery of siRNAs.
- Identified a novel clathrin/caveolin-independent endocytosis mechanism initiated by dextran.
- Demonstrated scavenger receptor-mediated endocytosis as the primary pathway.
Conclusions:
- Dextran functionalization of silica nanoparticles offers an effective strategy for enhancing siRNA delivery.
- The identified scavenger receptor-mediated pathway provides a new target for optimizing siRNA delivery systems.
- This approach holds potential for improving RNAi-based therapeutics across various cell types.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Modified-Release Drug Delivery Systems: Site-Targeted

